These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1714024)

  • 1. Cardiovascular effects of elgodipine in conscious pigs with a normal coronary circulation and in conscious pigs with a healed myocardial infarction.
    van Woerkens LJ; Schotman SN; van der Giessen WJ; Verdouw PD
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):976-82. PubMed ID: 1714024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
    Sassen LM; Soei LK; Koning MM; Verdouw PD
    Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of the novel potassium channel opener bimakalim in conscious pigs after myocardial infarction: a comparative study with nicorandil.
    van Woerkens LJ; Baas NR; van der Giessen WJ; Verdouw PD
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):409-17. PubMed ID: 1387797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of the new dihydropyridine derivative elgodipine.
    Tamargo J; López-Sendón J; Delpón E; González-Morales M; de Miguel E
    Arzneimittelforschung; 1991 Sep; 41(9):895-900. PubMed ID: 1796916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.
    Duncker DJ; Hartog JM; Hugenholtz PG; Saxena PR; Verdouw PD
    Br J Pharmacol; 1986 May; 88(1):9-18. PubMed ID: 2871886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog.
    Drieu la Rochelle CD; Grosset A; O'Connor SE
    Br J Pharmacol; 1994 Jan; 111(1):49-56. PubMed ID: 8012724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and antiischemic effects of intravenous elgodipine, a new dihydropyridine calcium channel blocker, in patients with chronic stable angina.
    Kuhn A; Carlsson J; Miketic S; Tebbe U
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):595-600. PubMed ID: 8547210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative hemodynamic effects of digoxin vs nitroprusside in conscious dogs with aortocaval fistula-induced chronic left ventricular volume overload and normal systolic performance.
    O'Rourke RA; Badke FR; Forst D
    Am Heart J; 1982 Apr; 103(4 Pt 1):489-97. PubMed ID: 6121480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic haemodynamic actions of pimobendan (UD-CG 115 BS) and its O-demethylmetabolite UD-CG 212 Cl in the conscious pig.
    Duncker DJ; Hartog JM; Levinsky L; Verdouw PD
    Br J Pharmacol; 1987 Jul; 91(3):609-15. PubMed ID: 3607369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties.
    Verdouw PD; Hartog JM; Duncker DJ; Roth W; Saxena PR
    Eur J Pharmacol; 1986 Jul; 126(1-2):21-30. PubMed ID: 2875884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic profile of the potassium channel activator EMD 52692 in anaesthetized pigs.
    Sassen LM; Duncker DJ; Gho BC; Diekmann HW; Verdouw PD
    Br J Pharmacol; 1990 Nov; 101(3):605-14. PubMed ID: 2076480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
    Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
    Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
    Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic haemodynamics of dihydropyridine derivatives in conscious pigs with or without propranolol.
    Duncker DJ; Saxena PR; Verdouw PD
    Eur J Pharmacol; 1988 Nov; 156(3):401-9. PubMed ID: 3215283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
    Harkin CP; Pagel PS; Tessmer JP; Warltier DC
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary vasodilatory action of elgodipine in coronary artery disease.
    Suryapranata H; Maas A; MacLeod DC; de Feyter PJ; Verdouw PD; Serruys PW
    Am J Cardiol; 1992 May; 69(14):1171-7. PubMed ID: 1575187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
    Uchida W; Shibasaki K; Asano M
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):60-8. PubMed ID: 1375689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren.
    van Kats JP; Sassen LM; Danser AH; Polak MP; Soei LK; Derkx FH; Schalekamp MA; Verdouw PD
    Br J Pharmacol; 1996 Mar; 117(5):891-901. PubMed ID: 8851507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.